Education
About Us
Working with TipRanks
Follow Us
Juan Graham Insider Profile
4 Followers
Juan Graham, CFO at Kyntra Bio, holds 35.35K shares in Perspective Therapeutics (Ticker: CATX), holds 164.86K shares in Kyntra Bio (Ticker: KYNB). Most recently, Juan Graham Bought ― shares of Perspective Therapeutics on Apr 01, 2025 for an estimated value of $74.67K.
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+80.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Juan Graham
Juan Graham's Trading History
Kyntra Bio
Dec 09, 2024
CFO
Uninformative Sell
854.08
$1.44M
Perspective Therapeutics
Apr 01, 2025
CFO
Informative Buy
74.67K
$95.81K
List of latest transactions for each holding click on a transaction to see Juan Graham's performance on stock
You May Also Like
Juan Graham insider profile FAQ
What is the percentage of profitable transactions made by Juan Graham?
The percentage of profitable transactions made by Juan Graham is 100%.
What is the average return per transaction made by Juan Graham?
The average return per transaction made by Juan Graham is 80.80%.
What stocks does Juan Graham hold?
Juan Graham holds: KYNB, CATX stocks.
What was Juan Graham’s latest transaction?
Juan Graham latest transaction was an Informative Buy of $74.67K.
What was Juan Graham's most profitable transaction?
Juan Graham’s most profitable transaction was an Informative Sell of KYNB stock on December 14, 2022. The return on the trade was 95.40%.
What is Juan Graham's role in Kyntra Bio?
Juan Graham's role in Kyntra Bio is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.